The White House has temporarily exempted India’s pharmaceutical sector from new US tariffs, offering relief amid global trade tensions. India charges a 10% tariff on US pharma imports, while the US imposes none on Indian pharma. The exemptions cover semiconductors, lumber, copper, gold, and pharmaceutical products, along with energy resources and rare minerals unavailable in the US.

#WatchOutFor#Today’sTradingSetup#FundamentalViews#PersonalFinance#Miscellaneous